| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.38 | 4e-12 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-09 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.23 | 8e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |